LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $471,000 | +59.1% | 55,000 | +128.2% | 0.03% | -33.3% |
Q3 2017 | $296,000 | +76.2% | 24,100 | +106.0% | 0.05% | -78.2% |
Q2 2016 | $168,000 | -48.5% | 11,700 | -57.1% | 0.23% | +67.1% |
Q1 2016 | $326,000 | +169.4% | 27,300 | +82.0% | 0.14% | +366.7% |
Q2 2015 | $121,000 | – | 15,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |